HOOKIPA Pharma Inc.

About HOOKIPA Pharma Inc.

Hookipa Pharma is dedicated to reprogramming the immune system to combat cancer and infectious diseases through innovative immunotherapy solutions. Their mission is to 'supercharge' the immune system's natural ability to fight disease using proprietary technologies.

Products & Services

Arenavirus Platform:A proprietary, flexible platform that engineers arenaviral therapeutics to mobilize and amplify targeted T cells and antibodies to fight or prevent serious diseases.

Immuno-Oncology Programs:Focused on developing therapies to combat cancer by enhancing immune responses.

Infectious Diseases Programs:Aimed at preventing and treating infectious diseases through immune system reprogramming.

Eseba-vec:A therapeutic candidate highlighted in clinical trials and presentations for various applications, including frontline HNSCC and adjuvant therapy.

HB-700:A preclinical therapeutic candidate with strong dataset presentations for potential disease treatment.

Specialties

Immunotherapy Arenavirus Platform T Cell Therapies Cancer Treatment Infectious Disease Prevention

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity T: - FT: Equity	A: 21250000 MR: - FA: $21.25 million FAN: 21250000	D: 2023-12-20 FD: 2023-12-20	1 investors

Equity Latest

2023-12-20

$21.2M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Rolf Zinkernagel

A

Andreas Bergthaler

Founder

L

Lukas Flatz

University Professor of Dermatology

D

Daniel Pinschewer

Founder and Scientific Advisor to the CEO

P

Peter Doherty

H

Hans Hengartner

View 11 more team members with Pro

Unlock Full Team Directory

Recent News